Rohde, C.M.; Lindemann, C.; Giovanelli, M.; Sellers, R.S.; Diekmann, J.; Choudhary, S.; Ramaiah, L.; Vogel, A.B.; Chervona, Y.; Muik, A.;
et al. Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines 2023, 11, 417.
https://doi.org/10.3390/vaccines11020417
AMA Style
Rohde CM, Lindemann C, Giovanelli M, Sellers RS, Diekmann J, Choudhary S, Ramaiah L, Vogel AB, Chervona Y, Muik A,
et al. Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines. 2023; 11(2):417.
https://doi.org/10.3390/vaccines11020417
Chicago/Turabian Style
Rohde, Cynthia M., Claudia Lindemann, Michael Giovanelli, Rani S. Sellers, Jan Diekmann, Shambhunath Choudhary, Lila Ramaiah, Annette B. Vogel, Yana Chervona, Alexander Muik,
and et al. 2023. "Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines" Vaccines 11, no. 2: 417.
https://doi.org/10.3390/vaccines11020417
APA Style
Rohde, C. M., Lindemann, C., Giovanelli, M., Sellers, R. S., Diekmann, J., Choudhary, S., Ramaiah, L., Vogel, A. B., Chervona, Y., Muik, A., & Sahin, U.
(2023). Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines. Vaccines, 11(2), 417.
https://doi.org/10.3390/vaccines11020417
